老年人药物相互作用与药物不良反应相关入院风险
该横断面研究纳入798例爱尔兰急性入院老年人(≥65岁),其中782例使用≥2种药物。40.4%存在至少一种潜在临床重要DDI。DDI暴露对ADR相关入院的平均因果效应aOR=1.21(95%CI 0.89-1.64),但增加出血风险的DDI、阿司匹林-华法林及埃索美拉唑-艾司西酞普兰显著增加ADR入院风险。
要点
- 40.4%的老年急性入院患者存在至少一种潜在临床重要DDI。
- 增加出血风险的DDI使ADR相关入院风险翻倍(aOR=2.00)。
- 阿司匹林-华法林和埃索美拉唑-艾司西酞普兰显著增加ADR入院风险。
核心结论
- 潜在临床重要DDI对ADR相关入院有升高的平均因果效应,出血风险相关DDI应作为药物优化靶点。
研究设计与样本
- 横断面研究,纳入2016-2017年爱尔兰798例急性入院老年人(≥65岁)。
- 使用BNF和Stockley's Drug Interactions识别DDI,采用有向无环图和多变量logistic回归估计平均因果效应。
主要发现
- 782例(98.0%)使用≥2种药物的患者纳入分析,平均年龄80.9(SD±7.5)岁,女性52.2%,45.1%(n=353)为ADR相关入院。
- 入院时316例(40.4% [95%CI: 37.0-43.9])存在至少一种DDI。
- DDI暴露对ADR相关入院的平均因果效应aOR=1.21 [95%CI: 0.89-1.64]。
- 增加出血风险的DDI aOR=2.00 [1.26-3.12];阿司匹林-华法林aOR=2.78 [1.37-5.65];埃索美拉唑-艾司西酞普兰aOR=3.22 [1.13-10.25]。
- DDI暴露者HRQoL较低(EQ-5D均值0.49 [±0.39] vs 0.57 [±0.41],P=.03),中位住院时间更长(8 [IQR 5-16]天 vs 7 [IQR 4-14]天,P=.04)。
临床怎么用
- 对老年患者应重点筛查增加出血风险的DDI(如阿司匹林-华法林)及埃索美拉唑-艾司西酞普兰等组合。
- 发现潜在临床重要DDI时,可考虑药物优化以降低ADR相关入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aims of this study were to estimate potentially clinically important drug-drug interaction (DDI) prevalence, and the average causal effect of DDI exposure on adverse drug reaction (ADR)-related hospital admission, and to examine differences in health-related quality of life (HRQoL) and length of stay (LOS) per DDI exposure in an older (≥65 years) population acutely hospitalized. METHODS: This was a cross-sectional study conducted among 798 older individuals acutely admitted to hospital in Ireland between 2016 and 2017. Medication (current/recently discontinued/over-the-counter) and clinical data (e.g., creatinine clearance) were available. DDIs were identified using the British National Formulary (BNF) and Stockley's Drug Interactions. Causal inference models for DDI exposure on ADR-related hospital admission were developed using directed acyclic graphs. Multivariable logistic regression was used to estimate the average causal effect. Differences in HRQoL (EQ-5D) and LOS per DDI exposure were examined non-parametrically. DDI prevalence, adjusted odds ratios (aOR), and 95% confidence intervals (CIs) are reported. RESULTS: A total of 782 (98.0%) individuals using two or more drugs were included. Mean age was 80.9 (SD ± 7.5) years (range: 66-105); 52.2% were female; and 45.1% (n = 353) had an ADR-related admission. At admission, 316 (40.4% [95% CI: 37.0-43.9]) patients had at least one DDI. The average causal effect of DDI exposure on ADR-related hospital admission was aOR = 1.21 [95% CI: 0.89-1.64]. This was significantly increased by exposure to: DDIs which increase bleeding risk (aOR = 2.00 [1.26-3.12]); aspirin-warfarin (aOR = 2.78 [1.37-5.65]); and esomeprazole-escitalopram (aOR = 3.22 [1.13-10.25]. DDI-exposed patients had lower HRQoL (mean EQ-5D = 0.49 [±0.39]) compared those non-DDI-exposed (mean EQ-5D = 0.57 [±0.41]), (P = .03); and greater median LOS in hospital (8 [IQR5-16]days) compared those non-DDI-exposed (7 [IQR 4-14] days),(P = .04). CONCLUSIONS: Potentially clinically important DDIs carry an increased average causal effect on ADR-related admission, significantly (two-fold) by exposure to DDIs that increase bleeding risk, which should be targeted for medicine optimization.
引用
- Hughes JE, Moriarty F, Bennett KE, et al. Drug-drug interactions and the risk of adverse drug reaction-related hospital admissions in the older population. Br J Clin Pharmacol. 2023. PMID: 37984336. doi:10.1111/bcp.15970
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。